Heart Failure in Late Pregnancy and Postpartum: Incidence and Long-Term Mortality in Sweden From 1997 to 2010

Journal of Cardiac Failure

Volumn 23, Issue 5, 2017, Pages 370-378

  Barasa, Anders ^a   Rosengren, Annika ^a   Sandström, Tatiana Zverkova ^a   Ladfors, Lars ^b   Schaufelberger, Maria ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiomyopathy; epidemiology; heart failure; pregnancy, postpartum

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; ICD-10; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MATERNAL OBESITY; MIDDLE INCOME COUNTRY; MORTALITY; MULTIPLE PREGNANCY; OBSTETRIC DELIVERY; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM; SWEDEN; SWEDISH CITIZEN; THIRD TRIMESTER PREGNANCY; TWINS; CASE CONTROL STUDY; EPIDEMIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PUERPERAL DISORDER; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; RISK FACTORS; SWEDEN;

EID: 85012925356     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.12.011     Document Type: Article

References (46)

1. Esscher, A., Excess mortality in women of reproductive age from low-income countries: a Swedish registry study. Eur J Public Health 23 (2012), 274–279.
2. Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., Mebazaa, A., Pieske, B., Buchmann, E., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail 12 (2010), 767–778.
3. Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., Bauersachs, J., Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36 (2015), 1090–1097.
4. Hilfiker-Kleiner, D., Sliwa, K., Pathophysiology and epidemiology of peripartum cardiomyopathy. Nature Rev Cardiol 11 (2014), 364–370.
5. Desai, D., Moodley, J., Naidoo, D., Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 25 (1995), 118–123.
6. Brar, S.S., Khan, S.S., Sandhu, G.K., Jorgensen, M.B., Parikh, N., Hsu, J.W., et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100 (2007), 302–304.
7. Goland, S., Modi, K., Bitar, F., Janmohamed, M., Mirocha, J.M., Czer, L.S., et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15 (2009), 645–650.
8. Mielniczuk, L.M., Williams, K., Davis, D.R., Tang, A.S., Lemery, R., Green, M.S., et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 97 (2006), 1765–1768.
9. Chapa, J.B., Heiberger, H.B., Weinert, L., Decara, J., Lang, R.M., Hibbard, J.U., Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 (2005), 1303–1308.
10. Kamiya, C.A., Kitakaze, M., Ishibashi-Ueda, H., Nakatani, S., Murohara, T., Tomoike, H., et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide Survey of Peripartum Cardiomyopathy. Circ J 75 (2011), 1975–1981.
11. Halkein, J., Tabruyn, S.P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.Q., Scherr, M., et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123 (2013), 2143–2154.
12. Patten, I.S., Rana, S., Shahul, S., Rowe, G.C., Jang, C., Liu, L., et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485 (2012), 333–338.
13. McNamara, D.M., Elkayam, U., Alharethi, R., Damp, J., Hsich, E., Ewald, G., et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 66 (2015), 905–914.
14. Ware, J.S., Seidman, J.G., Arany, Z., Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 374 (2016), 2601–2602.
15. Arany, Z., Elkayam, U., Peripartum cardiomyopathy. Circulation 133 (2016), 1397–1409.
16. Haghikia, A., Podewski, E., Libhaber, E., Labidi, S., Fischer, D., Roentgen, P., et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol, 108, 2013, 366.
17. Kao, D.P., Hsich, E., Lindenfeld, J., Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 1 (2013), 409–416.
18. Harper, M.A., Meyer, R.E., Berg, C.J., Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol 120 (2012), 1013–1019.
19. Gentry, M.B., Dias, J.K., Luis, A., Patel, R., Thornton, J., Reed, G.L., African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 55 (2010), 654–659.
20. Blauwet, L.A., Libhaber, E., Forster, O., Tibazarwa, K., Mebazaa, A., Hilfiker-Kleiner, D., et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 99 (2013), 308–313.
21. Swedish National Board of Health and Welfare, Pregnancies, deliveries and new born infants. 2012.
22. Olausson, P.O., External review and validation of the Swedish Medical Birth Registry. Epidemiologiskt Centrum (Centre of Epidemiology, National Board of Health and Welfare), 2002.
23. Lee, P.A., Chernausek, S.D., Hokken-Koelega, A.C., Czernichow, P., International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001. Pediatrics 111:6 Pt 1 (2003), 1253–1261.
24. Swedish National Board of Health and Welfare, Causes of death 2009. [Dödsorsaker 2009] (Addendum: Cause of death statistics—history, methods of production and validity [Dödsorsaksstatistik—historie, produktionsmetoder och tillförlitlighet]), 2009.
25. Ludvigsson, J.F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.L., Reuterwall, C., et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.
26. Ingelsson, E., Arnlov, J., Sundstrom, J., Lind, L., The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 (2005), 787–791.
27. Gunderson, E.P., Croen, L.A., Chiang, V., Yoshida, C.K., Walton, D., Go, A.S., Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol 118 (2011), 583–591.
28. Elkayam, U., Akhter, M.W., Singh, H., Khan, S., Bitar, F., Hameed, A., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 (2005), 2050–2055.
29. Owan, T., Litwin, S.E., Is there a cardiomyopathy of obesity?. Curr Heart Fail Rep 4 (2007), 221–228.
30. Khan, M.F., Movahed, M.R., Obesity cardiomyopathy and systolic function: obesity is not independently associated with dilated cardiomyopathy. Heart Fail Rev 18 (2013), 207–217.
31. Sebillotte, C.G., Deligny, C., Hanf, M., Santiago, R., Chevallier, J.C., Volumenie, J.L., et al. Is African descent an independent risk factor of peripartum cardiomyopathy?. Int J Cardiol 145 (2010), 93–94.
32. Fett, J.D., Christie, L.G., Carraway, R.D., Murphy, J.G., Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80 (2005), 1602–1606.
33. Malebranche, R., Tabou Moyo, C., Morisset, P.H., Raphael, N.A., Wilentz, J.R., Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of the State University of Haiti. Am Heart J 178 (2016), 151–160.
34. Demakis, J.G., Rahimtoola, S.H., Sutton, G.C., Meadows, W.R., Szanto, P.B., Tobin, J.R., et al. Natural course of peripartum cardiomyopathy. Circulation 44 (1971), 1053–1061.
35. Witlin, A.G., Mabie, W.C., Sibai, B.M., Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 176:1 Pt 1 (1997), 182–188.
36. Jeyabalan, A., Epidemiology of preeclampsia: impact of obesity. Nutr Rev 71:Suppl 1 (2013), S18–25.
37. Bello, N., Rendon, I.S., Arany, Z., The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 62 (2013), 1715–1723.
38. Young, B.C., Levine, R.J., Karumanchi, S.A., Pathogenesis of preeclampsia. Annu Rev Pathol 5 (2010), 173–192.
39. Ntusi, N.B., Badri, M., Gumedze, F., Sliwa, K., Mayosi, B.M., Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS ONE, 10, 2015 e0133466.
40. Bibbins-Domingo, K., Pletcher, M.J., Lin, F., Vittinghoff, E., Gardin, J.M., Arynchyn, A., et al. Racial differences in incident heart failure among young adults. N Engl J Med 360 (2009), 1179–1190.
41. Vázquez Blanco, M.R.J., Grosso, O., Rodriguez, G., Robert, S., Berensztein, C.S., Vega, H.R., et al. Left ventricular function impairment in pregnancy-induced hypertension. Am J Hypertens 14 (2001), 271–275.
42. Rafik Hamad, R., Larsson, A., Pernow, J., Bremme, K., Eriksson, M.J., Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens 27 (2009), 2257–2264.
43. Dennis, A.T., Castro, J., Carr, C., Simmons, S., Permezel, M., Royse, C., Haemodynamics in women with untreated pre-eclampsia. Anaesthesia 67 (2012), 1105–1118.
44. Kroneman, M., Siegers, J.J., The effect of hospital bed reduction on the use of beds: a comparative study of 10 European countries. Soc Sci Med 59 (2004), 1731–1740.
45. Duran, N., Gunes, H., Duran, I., Biteker, M., Ozkan, M., Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 101 (2008), 137–140.
46. Mandal, D., Mandal, S., Mukherjee, D., Biswas, S.C., Maiti, T.K., Chattopadhaya, N., et al. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res 37 (2011), 222–227.